Next Article in Journal
Monocyte Distribution Width as a Biomarker for Predicting Bacteremia: A Retrospective Study in the Emergency Department
Previous Article in Journal
Spatial Cluster of Air Pollutants and Its Association with Life Expectancy, Age-Specific Mortality Risk, and Cause-Specific Mortality Rate: A County-Level Ecological Study Across the USA
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data

by
Diego Armando Villamizar Mantilla
1,
Luis Alberto Nuñez
2,3,
Elena E. Stashenko
4,
María Pilar Vinardell
5,* and
Jorge Luis Fuentes
1,4,*
1
Laboratorio de Microbiología y Mutagénesis Ambiental (LMMA), Grupo de Investigación en Microbiología y Genética, Escuela de Biología, Facultad de Ciencias, Universidad Industrial de Santander (UIS), Bucaramanga 680002, Colombia
2
Escuela de Física, Facultad de Ciencias, Universidad Industrial de Santander, Bucaramanga 680002, Colombia
3
Departamento de Física, Universidad de Los Andes, Mérida 5101, Venezuela
4
Centro de Investigación en Biomoléculas, CIBIMOL, Facultad de Ciencias, Universidad Industrial de Santander (UIS), Bucaramanga 680002, Colombia
5
Departamento de Bioquímica y Fisiología, Facultad de Farmacia y Ciencias de la Alimentación, Universitat de Barcelona, 08028 Barcelona, Spain
*
Authors to whom correspondence should be addressed.
Life 2026, 16(1), 176; https://doi.org/10.3390/life16010176
Submission received: 24 December 2025 / Revised: 15 January 2026 / Accepted: 16 January 2026 / Published: 21 January 2026
(This article belongs to the Section Physiology and Pathology)

Abstract

Background: Plants represent an important source of photoprotective compounds that are capable of protecting human skin from solar-induced damage. In this study we investigated the suitability of a murine model for estimating the Erythema Protection Efficacy (EPE) of natural compound. Methods: UVB-induced skin erythema in albino BALB/c mice was quantified using a Mexameter MX18 MDD colorimeter. The ARRIVE principle was followed. The Minimum Erythema Dose (MED) was determined based on Log10 dose–erythema response curves. EPE values for UV filters (e.g., titanium dioxide or zinc oxide) and selected plant-derived compounds (apigenin, caffeic acid, epigallocatechin gallate, kaempferol, and pinocembrin) were calculated as the ratio between the MED of protected skin and that of unprotected skin. Results: The UVB-induced erythema in both female and male mouse skin followed a linear response. Erythema intensity varied by sex and by the dorsal skin area examined. MED values ranged from 39 to 57 mJ/cm2 in female mice and from 71 to 80 mJ/cm2 in male mice. In both sexes, MED increased linearly with the logarithm of the radiation dose. All tested compounds (apigenin, caffeic acid, epigallocatechin gallate, kaempferol, and pinocembrin) provided protection against UV-radiation-induced erythema in mouse skin. Among them, apigenin, caffeic acid, and kaempferol exhibited the highest EPE values, indicating strong potential for incorporation into sunscreen formulations. Conclusions: The murine EPE metric proved to be a useful tool for identifying plant-derived compounds with potential relevance for the photoprotection of human skin.

1. Introduction

Overexposure of human skin to solar radiation represents a public health problem due to its well-stablished carcinogenic effects [1,2]. Ultraviolet (UV) radiation induces the formation of cyclobutane pyrimidine dimers (CPDs), which initiate mutagenic, inflammatory, and carcinogenic processes in human skin [3]. Young et al. [4] were the first to demonstrate a direct relationship between UV-induced CPD formation and skin erythema, proposing erythema as a surrogate marker of UV-induced DNA damage. Consequently, measurements of UV-induced erythema, particularly the MED, have become essential for evaluating the efficacy of photoprotective strategies for human skin [5,6].
Phytochemicals are well-known for their antioxidant, chemopreventive, and anti-inflammatory properties as well as their ability to mitigate UV-radiation-induced skin damage [7,8]. Using a narrow-band reflectance method [9], we previously demonstrated that phytochemicals inhibit UV-induced erythema in murine skin [10]. Our study suggested that applying the narrow-band reflectance method in a murine model is an effective approach for screening and identifying photoprotective phytochemicals.
There are at least three main reasons to develop alternative approaches to the Sun Protection Factor (SPF) metric [5] for assessing the photoprotective activity of sunscreen ingredients. First, the current “gold standard” method (European Standard ISO 24444:2019), which is conducted in human volunteers [11,12], is laborious and costly because it requires specialized equipment, limiting its applicability in large-scale phytochemical screening. Second, the gold standard approach may occasionally cause skin damage in sensitive volunteers, raising ethical concerns. For similar reasons, in vivo studies of the biological effects of photoprotective compounds cannot be conducted extensively in humans. In this context, murine models represent a valuable alternative for screening molecules with anti-erythema activity under UV radiation and for mechanistic studies [10]. Third, the alternative in vitro method used to evaluate the photoprotective efficacy of sunscreens (European Standard ISO 24443:2012) uses polymethylmethacrylate (PMMA) as a substrate, which is a plastic matrix that differs substantially from human skin. Consequently, this method is not suitable for studying the photoprotection mechanisms of sunscreen ingredients, particularly those involved in preventing UV-induced DNA damage or carcinogenic processes in human skin. Such mechanisms can be reliably investigated using a mammalian skin matrix.
The present study hypothesized that a murine model could be used to establish an EPE metric analogous to the human Sun Protection Factor (SPF), thereby facilitating the screening of phytochemicals with potential applications in human skin photoprotection. According, this study aimed to characterize UVB-induced erythema kinetics in albino BALB/c mice using narrow-band reflectance methods, determine the MED in murine skin, and determine a stable EPE metric for conventional UV filters and plant-derived compounds.

2. Materials and Methods

2.1. UVB-Induced Erythema Kinetics

We used albino BALB/c mice purchased from the Corporation for Biological Research (CIB, Medellín, Colombia). Animal maintenance, preparation for experiments, and irradiation were conducted as previously described [10]. The ARRIVE principle was followed. The kinetics of UVB-induced erythema in mice skin were studied at radiation doses of 70–200 mJ/cm2. Erythema was measured using a Mexameter MX18 MDD model colorimeter (Courage–Khazaka Electronic, Cologne, Germany). The Mexameter colorimeter measured absorbed and reflected light at three wavelengths: green λ = 568 nm, red λ = 660 nm, and infrared λ = 870 nm. From the quantity of emitted light, the amount of light absorbed by the skin was calculated. The hemoglobin (erythema) value was computed based on the measured back-reflected light in the green (568 nm) and red (660 nm) bands as follows [13]: hemoglobin (erythema) = 500/log5 × [log (red-reflection/green-reflection) + log5]. Measurements were performed immediately pre-irradiation (0 h) as well as 24 and 48 h after irradiation of the upper, middle, and lower back dorsal areas (1 cm2 each) of 36 subjects (18 female + 18 male mice). This colorimeter probe featured a spring that maintained constant pressure on the skin, enabling automatic absorbance and reflectance measurements on a 5 mm surface diameter. UVB-induced erythema in mice was computed by normalizing to untreated skin as follows: Erythema Index (EI) = reflectance of irradiated skin − reflectance of nonirradiated skin [14]. The mean EI value for each treatment (radiation dose) and corresponding standard errors were calculated (n = 3) and plotted using the ggplot2 program in R software [15]. Thus, the best erythema kinetic function was determined. The MED values in the mice were calculated graphically based on Log10 dose–erythemal response curves [16], using data from 36 subjects (n = 18 females and 18 males).

2.2. Erythema Protection Efficacy of the Compounds in Mice

We determined EPE values for standard filters (e.g., titanium dioxide and zinc oxide) and plant-derived compounds (e.g., apigenin, caffeic acid, epigallocatechin gallate (EGCG), kaempferol, and pinocembrin,) purchased from Sigma-Aldrich Co. Inc. (Milwaukee, WI, USA). The mice were grouped as follows: A, untreated mice; B, mice treated only with humectant vehicle (25% glycerin); C, mice treated with humectant and irradiated at doses between 200 and 1200 mJ/cm2; and D, mice treated with the humectant, compound (μg/cm2), and irradiated at the dose used in treatment C. All treatments were applied to the upper back of each mouse (n = 3). Because plant-derived compounds exhibit diverse solubility profiles, compound-specific solvents were selected for the preparation of the stock solutions [10]. Then, the stock solutions were mixed with 4 μL of pure glycerin humectant vehicle (Laboratorios León S.A., Bucaramanga, Colombia) and with distilled water until reaching a spreading volume (16 μL) and compound concentrations as follows: apigenin (48.6 μg/cm2), caffeic acid (80.7 μg/cm2), EGCG (198 μg/cm2), kaempferol (100 μg/cm2), and pinocembrin (24.5 μg/cm2). These concentrations were selected based on their in vitro effective photoprotection, photostability, and safety in human fibroblast cells [17]. The standard filters, titanium dioxide (500 μg/cm2) and zinc oxide (500 μg/cm2), were prepared at a concentration (25% in the mixture) recommended for human photoprotection [18]. The Erythema Inhibition Percentage (EIP) was computed for each cotreatment as follows: EIP = 1 − (EIp/EIu) × 100, where EIp is the EI value of protected mice skin, and EIu is the EI value of unprotected mice skin.
Based on the SPF metric [12], we computed EPE values for each compound as follows: EPE = M E D p M E D u , where MEDp is the minimal erythemal dose of an individual subject’s protected skin (compound tested), and MEDu is the minimal erythemal dose of an individual subject’s unprotected skin (humectant vehicle + UVB radiation). Since incomplete or partial photoprotection can occur at doses higher than the MEDp (see Figure S1), we computed a corrected EPE index considering the area under the curve of the incomplete protection zone as follows: EPEc = EPE + D m a x M E D p   M E D u   S E D   d D g ( D ) E 0 + S E D M E D p     d D E 1 E 0 M E D p   D m a x   d D E 1 f ( D ) , where EPE is the erythema protective efficacy of the sample as indicated above, Dmax is the maximum dose to the incompletely protected zone, SED is the saturation erythema dose delivered to the completely protected zone, E0 and E1 are the erythema indices (EI) at MEDu and MEDp, respectively, and g(D) and f(D) are the erythema index values as a function of dose.

2.3. Statistical Analysis

The average IE, MED, EPE, and EPEC values, along with their corresponding standard errors, were calculated. The data passed the Kolmogorov–Smirnov and F-maximum tests for normality and variance homogeneity, respectively. Therefore, the groups were subsequently compared using the parametric Tukey’s test. A Pearson’s product–moment correlation analysis was used to estimate relation between radiation dose and EI estimates, as well as between EPE or EPEC and the expected human SPF estimates. For all statistical analyses, a p-value < 0.05 indicated statistical significance. The R platform [15] was used for all analyses.

3. Results

3.1. UVB-Induced Skin Erythema in Albino BALB/c Mice

UVB-induced skin damage in BALB/c mice was studied (Figure 1). Visible skin damage in UVB-irradiated mice was classified as follows: female: erythema (71%), burns (20%), pigmentation (9%); and males: erythema (62%), burns (30%), and pigmentation (8%).
The degree of UVB-induced erythema was measured using narrow-band reflectance spectroscopy (Table 1). Skin reflectance increased from pre-irradiation (0 h) to 48 h post-irradiation. The EI values of the mouse skin depended on radiation dose (R = 0.79–0.98, p ˂ 0.05), and these were consistently higher in females than in males. Additionally, the EI values varied, with the EI in back dorsal area being higher in upper areas.
A linear graphical method based on Log10 dose–erythemal response curves permitted the estimation of the threshold dose (X-axis intercept) or MED (Figure 2).
The erythema dose–response curves fit a linear function, showing the best fit (R = 0.84–0.96, p < 6.3 × 10−13) for the upper back dorsal area. The MED values varied depending on sex and dorsal region as follows: females: upper back (39 mJ/cm2) < central back (51 mJ/cm2) < lower back (57 mJ/cm2); males: lower back (71 mJ/cm2) < central back (77 mJ/cm2) < upper back (80 mJ/cm2). This confirmed that female mice were more sensitive to UVB radiation than male mice.

3.2. Erythema Protection Efficacy of Phytochemicals

To determine the EPE values for each compound, we studied UVB-induced erythema in the presence and absence of plant-derived compounds on the upper back area, which showed the best linear function fit (see Figure 2) in both female (R = 0.96, p < 2.2 × 10−16) and male (R = 0.84, p < 6.3 × 10−16) mice.
Table 2 presents the reflectance and EI values of the different treatments. For all treatments, reflectance values increased from the time of irradiation (0 h) to 48 h post-irradiation in both female and male mice. Exposure to 200 mJ/cm2 of UVB radiation increased the EI values relative to the negative control. Cotreatment with glycerin (25%) + UVB radiation (200 mJ/cm2) also increased the EI values compared with the negative control, although this increase was slightly lower than that observed in UVB-irradiated (200 mJ/cm2) mouse skin. Because glycerin was used as an emollient to facilitate the application of all treatments to mouse skin, the EI value obtained in the cotreatment with glycerin + UVB radiation (200 mJ/cm2) (highlighted in bold) was used as the reference control for comparison in phytochemical-UVB cotreatment experiments.
Cotreatment with apigenin (48.6 µg/cm2), caffeic acid (448 µM/cm2), EGCG (431 µM/cm2), and kaempferol (349 µM/cm2) significantly reduced UVB-induced erythema and showed a relevant EIP value (EIP ≥ 50%) at UVB doses of 400, 800, 400, and 800 mJ/cm2, respectively. Pinocembrin (95.61 µM/cm2) significantly reduced the induced erythema at a UVB dose of 400 mJ/cm2 and achieved a relevant EIP value at 200 mJ/cm2.
We calculated the EPE metric to quantify the effectiveness of the tested compounds (Table 3). Based on the EPE values, the relative photoprotective efficacy ranked as follows: kaempferol (20.5 ± 0.0) > apigenin = titanium dioxide = zinc oxide (15.4 ± 0.0) > caffeic acid (10.0 ± 0.0) > pinocembrin (5.0 ± 0.0) > EGCG (2.5 ± 0.0). These results demonstrated that low doses of kaempferol (100 µg/cm2) and apigenin (48.6 µg/cm2) yielded EPE values higher than, or similar to, those obtained with conventional inorganic filters (titanium dioxide or zinc oxide) applied at 500 µg/cm2. These results support the potential utility of the evaluated phytochemicals as UV filters in sunscreen formulations.
Because incomplete photoprotection may occur at doses higher than the MEDp (Figure S1), corrected EPE (EPEc) values were calculated for each compound (Table 3). The corrected ranking was as follows: kaempferol (23.4 ± 0.0) ˃ titanium dioxide = zinc oxide (20.1 ± 0.0) ˃ apigenin (19.9 ± 0.0) ˃ caffeic acid (13.4 ± 0.0) ˃ pinocembrin (7.6 ± 0.0) ˃ EGCG (3.4 ± 0.0). Table 3 also presents the predicted SPF values (SPF = MEDp/human MED) for each photoprotective compound for each human phototype (I–IV). The Pearson’s product–moment correlation analysis indicated moderate to high correlations between EPE or EPEC and expected human SPF estimates. These predictions suggest that apigenin, caffeic acid, and kaempferol can be used not only as antioxidants but also as effective UV-filter ingredients in sunscreen formulations. Our results support the potential of these plant-derived compounds in human skin photoprotection.

4. Discussion

This study describes the erythema dose–response kinetics in mouse skin following exposure to artificial UVB radiation. The observed kinetics were comparable to those previously reported for human skin [20,21]. The Log10 dose–erythema response curves enabled the calculation of the threshold dose, defined as the X-axis intercept or MEDu, using an approach analogous, to that applied in human studies [16,22]. The MEDu values obtained in BALB/c mice (39–80 mJ/cm2) were slightly lower but comparable to those reported for visually scored erythema in mouse skin (41–92 mJ/cm2) [23]. Our results demonstrated that UVB-induced erythema was more pronounced in female mice than in male mice and varied with the dorsal skin area assayed. These differences may be associated with regional variations in skin vascularization, as enhanced vascularization has previously been correlated with increased erythema responses in mice [24]. Consistent with published reports, MEDu values are known to vary with skin phototype in humans [19,21,25] and genetic background in mice [23].
Despite the increasing interest in plant species as sources of photoprotective agents [7,8,26], only a limited number of phytochemicals, such as caffeic, ferulic, and chlorogenic acids, and EGCG, have demonstrated photoprotective efficacy in vivo [27,28,29,30,31]. In the present study, we report EPE values for several phytochemicals (apigenin, caffeic acid, EGCG, kaempferol, and pinocembrin) that have previously exhibited photoprotective activity in vitro [32,33]. Our results indicate that these compounds reduce UVB-induced skin erythema in vivo in a manner comparable to that of established inorganic UV filters, such as titanium dioxide and zinc oxide. As reported in a previous study [34], our data also highlight the critical role of solvents in photoprotection. For instance, EGCG exhibited low protection (EPE = 2.5 ± 0.0), despite prior evidence of its in vivo photoprotective activity [27,29]. This discrepancy may be attributed to differences in the polarity of the solvent and vehicle composition (acetone and glycerin), which can affect compound solubility, skin distribution, and uniformity of application, thereby influencing photoprotection measurements.
Our results are consistent with previous reports on the skin-protective properties of these phytochemicals, including anti-inflammatory and chemopreventive effects [see Table S1]. Previous studies [35,36] have shown that pinocembrin and kaempferol exhibit antigenotoxic activity against UVB radiation in human embryo kidney and fibroblast cells. In addition, kaempferol has been reported to promote DNA damage repair in mouse skin after UV irradiation. These antigenotoxic effects may be attributed to mechanisms such as the inhibition of cyclobutene pyrimidine dimer (CPD) formation, enhanced CPD removal, and the restoration of normal cell cycle progression. All these findings highlight the strong potential of these phytochemicals for cosmetic and sunscreen applications. Furthermore, we have recently demonstrated that several plant species, including Posoqueria latifolia, and Rosa centifolia, represent natural sources of bioactive phytochemicals [37]. However, the development of cost-effective isolation processes will be essential to ensure a stable and sustainable supply of these raw materials.
The narrow-band reflectance method has been proven useful for the assessment of multiple dermatological conditions in humans [9,13,38]. In the present study, we demonstrate that the Mexameter MX18 colorimeter (Courage–Khazaka Electronic, Cologne, Germany) produces reproducible results, providing, a cost-effective alternative approach for estimating photoprotective efficacy during early-stage photoprotective compound screening. The EPE metric also correlated to expected human SPF estimates, especially SPFC metric. Because the EPE index is based on in vivo erythema measurements, compounds identified using this approach are expected to be relevant for human photoprotection.

5. Conclusions

UVB-induced erythema in mouse skin exhibits a linear kinetic response up to a dose of 200 mJ/cm2. The MEDu values obtained from BALB/c mice (39–80 mJ/cm2) were slightly lower but comparable to those previously reported for visually scored erythema in mouse skin (41–92 mJ/cm2). Plant-derived compounds including apigenin, caffeic acid, EGCG, kaempferol, and pinocembrin showed photoprotective effects in mice, with apigenin, caffeic acid, and kaempferol being the most promising candidates for inclusion in sunscreen formulations. Quantitative erythema measurements using mice facilitate the calculation of EPE values during the bioprospecting of plant-derived UV-filter compounds. The EPE metric, particularly the SPFC estimate, correlated with the expected human SPF values for the compounds studied. Therefore, the EPEC metric shows potential for predicting human photoprotection.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/life16010176/s1, Figure S1: Protection scenario in mice for evaluated compounds. We indicated doses and erythema index values relevant to calculated EPE index in mice as described in material and methods: MED is the minimal erythema dose, Dmax is the maximum doses to the incomplete protection zone, SED is the saturation erythema doses to the complete protection zone, E0 and E1 are the erythema indexes (EI) values at MEDu and MEDp, respectively, and g(D) and f(D) are the erythema index values as a dose function; Table S1: Previous studies that have reported protection of the studied plant compounds against UV-induced skin injuries in mammalian models. Effective concentrations of the studied compounds were given.

Author Contributions

The authors confirm their contributions to this paper: conceptualization, M.P.V., L.A.N. and J.L.F.; methodology, D.A.V.M., software, L.A.N.; formal analysis, D.A.V.M., L.A.N. and J.L.F.; data curation, D.A.V.M. and J.L.F.; writing—original draft preparation, D.A.V.M.; writing—review and editing, E.E.S., M.P.V., L.A.N., and J.L.F.; project administration, E.E.S. and J.L.F.; funding acquisition, E.E.S. and J.L.F. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Ministry of Science, Technology, and Innovation, the Ministry of Education, the Ministry of Industry, Commerce, and Tourism, ICETEX, Program Ecosistema Científico-Colombia Científica, and by the Francisco José de Caldas Fund, grant RC-FP44842-212-2018.

Institutional Review Board Statement

The project RC-FP44842-212-2018 was approved by the Scientific Research Ethics Committee (Record No. 15–2017, File No. 4110; Approval date: June 23, 2017) from the Universidad Industrial de Santander. The experiments and chemical management were performed following national law (Resolution No. 008430-1993) of the Ministry of Health of Colombia and the Institutional Manual of Integrated Management and Processes (PGIR–PGGA.05).

Informed Consent Statement

Not applicable.

Data Availability Statement

All data, tables, and figures are original.

Acknowledgments

The authors are grateful for the funding from the Ministry of Science, Technology, and Innovation, the Ministry of Education, the Ministry of Industry, Commerce, and Tourism, ICETEX, Program Ecosistema Científico-Colombia Científica, and the Francisco José de Caldas Fund. We thank the anonymous reviewers whose feedback contributed to improvements in our manuscript.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
CPDsCyclobutane pyrimidine dimers
EGCGEpigallocatechin gallate
EIErythema Index
EIpEI of protected mice skin
EIuEI of unprotected mice skin
EIPErythema Inhibition Percentage
EPEErythema Protection Efficacy
EPEcCorrected EPE
MEDMinimum Erythema Dose
MEDpMED of protected skin
MEDuMED of unprotected skin
SPFSun Protection Factor

References

  1. Martens, M.C.; Seebode, C.; Lehmann, J.; Emmert, S. Photocarcinogenesis and skin cancer prevention strategies: An update. Anticancer. Res. 2018, 38, 1153–1158. [Google Scholar] [CrossRef] [PubMed]
  2. Islami, F.; Sauer, A.G.; Miller, K.D.; Fedewa, S.A.; Minihan, A.K.; Geller, A.C.; Lichtenfeld, J.L.; Jemal, A. Cutaneous melanomas attributable to ultraviolet radiation exposure by state. Int. J. Cancer 2020, 147, 1385–1390. [Google Scholar] [CrossRef]
  3. Al-Sadek, T.; Yusuf, N. Ultraviolet radiation biological and medical implications. Curr. Issues Mol. Biol. 2024, 46, 1924–1942. [Google Scholar] [CrossRef] [PubMed]
  4. Young, A.R.; Harrison, G.I.; Chadwick, C.A.; Nikaido, O.; Ramsden, J.; Potten, C.S. The similarity of action spectra for thymine dimers in human epidermis and erythema suggests that DNA is the chromophore for erythema. J. Investig. Dermatol. 1998, 111, 982–988. [Google Scholar] [CrossRef] [PubMed]
  5. Osterwalder, U.; Herzog, B. Sun protection factors: World-wide confusion. Br. J. Dermatol. 2009, 161, 13–24. [Google Scholar] [CrossRef]
  6. Osterwalder, U.; Sohn, M.; Herzog, B. Global state of sunscreens. Photodermatol. Photoimmunol. Photomed. 2014, 30, 62–80. [Google Scholar] [CrossRef]
  7. Chhabra, G.; Ndiaye, M.A.; Garcia-Peterson, L.M.; Ahmad, N. Melanoma Chemoprevention: Current status and future prospects. Photochem. Photobiol. 2017, 93, 975–989. [Google Scholar] [CrossRef]
  8. Montes de Oca, M.K.; Pearlman, R.L.; McClees, S.F.; Strickland, R.; Afaq, F. Phytochemicals for the prevention of photocarcinogenesis. Photochem. Photobiol. 2017, 93, 956–974. [Google Scholar] [CrossRef]
  9. Abdlaty, R.; Hayward, J.; Farrell, T.; Fang, Q. Skin erythema and pigmentation: A review of optical assessment techniques. Photodiagn. Photodyn. Ther. 2021, 33, 102127. [Google Scholar] [CrossRef]
  10. Villamizar-Mantilla, D.A.; Stashenko, E.E.; Fuentes-Lorenzo, J.L. Plant compounds inhibit UV radiation-induced erythema in mice skin. Nat. Prod. Res. 2025, 1–8. [Google Scholar] [CrossRef]
  11. European Standard ISO24444; Cosmetics—Sun Protection Test Methods—In Vivo Determination of the Sun Protection Factor (SPF) (ISO24444:2019) (Second Edition). International Standard ISO Copyright Office: Geneva, Switzerland, 2019.
  12. Food and Drug Administration. Labeling and effectiveness testing; sunscreen drug products for over-the-counter human use. Final rule. Fed. Reg. 2011, 76, 35620–35665. [Google Scholar]
  13. Yoshimura, K.; Harii, K.; Masuda, Y.; Takahashi, M.; Aoyama, T.; Iga, T. Usefulness of a narrow-band reflectance spectrophotometer in evaluating effects of depigmenting treatment. Aesthetic Plast. Surg. 2001, 25, 129–133. [Google Scholar] [CrossRef]
  14. Wang, Y.Y.; Hong, C.T.; Chiu, W.T.; Fang, J.Y. In vitro and in vivo evaluations of topically applied capsaicin and nonivamide from hydrogels. Int. J. Pharm. 2001, 224, 89–104. [Google Scholar] [CrossRef] [PubMed]
  15. R Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2013; Available online: http://www.R-project.org (accessed on 10 September 2025).
  16. Poon, T.S.; Kuchel, J.M.; Badruddin, A.; Halliday, G.M.; Barnetson, R.S.; Iwaki, H.; Hatao, M. Objective measurement of minimal erythema and melanogenic doses using natural and solar-simulated light. Photochem. Photobiol. 2003, 78, 331–336. [Google Scholar] [CrossRef]
  17. Villamizar-Mantilla, D.A.; Flórez-González, S.J.; Pedraza-Barrera, C.A.; Stashenko, E.E.; Vinardell, M.P.; Fuentes, J.L. In vitro cytotoxicity, UV-filter and antigenotoxic properties of plant compounds as sunscreen ingredients. Chem. Biodivers. 2025, 22, e01383. [Google Scholar] [CrossRef]
  18. Jansen, R.; Osterwalder, U.; Wang, S.Q.; Burnett, M.; Lim, H.W. Photoprotection part II. Sunscreen: Development, efficacy, and controversies. J. Am. Acad. Dermatol. 2013, 69, 867.e1–867.e14. [Google Scholar] [CrossRef]
  19. Valbuena, M.C.; Nova-Villanueva, J.A.; Sánchez-Vanegas, G. Minimal Erythema Dose: Correlation with Fitzpatrick skin type and concordance between methods of erythema assessment in a patient sample in Colombia. Actas Dermo-Sifiliogr. 2020, 111, 390–397. [Google Scholar] [CrossRef]
  20. Wan, S.; Parrish, J.A.; Jaenicke, K.F. Quantitative evaluation of ultraviolet induced erythema. Photochem. Photobiol. 1983, 37, 643–648. [Google Scholar] [CrossRef] [PubMed]
  21. Harrison, G.A.; Young, A.R. Ultraviolet radiation-induced erythema in human skin. Methods 2002, 28, 14–19. [Google Scholar] [CrossRef] [PubMed]
  22. Diffey, B.L.; Farr, P.M.; Oakley, A.M. Quantitative studies on UVA-induced erythema in human skin. Br. J. Dermatol. 1987, 117, 57–66. [Google Scholar] [CrossRef]
  23. Gyöngyösi, N.; Lőrincz, K.; Keszeg, A.; Haluszka, D.; Bánvölgyi, A.; Tátrai, E.; Kárpáti, S.; Wikonkál, N.M. Photosensitivity of murine skin greatly depends on the genetic background: Clinically relevant dose as a new measure to replace minimal erythema dose in mouse studies. Exp. Dermatol. 2016, 25, 519–525. [Google Scholar] [CrossRef] [PubMed]
  24. Hirakawa, S.; Fujii, S.; Kajiya, K.; Yano, K.; Detmar, M. Vascular endothelial growth factor promotes sensitivity to ultraviolet B-induced cutaneous photodamage. Blood 2005, 105, 2392–2399. [Google Scholar] [CrossRef]
  25. Dornelles, S.; Goldlm, J.; Cestari, T. Determination of the minimal erythema dose and colorimetric measurements as indicators of skin sensitivity to UVB radiation. Photochem. Photobiol. 2004, 79, 540–544. [Google Scholar] [CrossRef]
  26. Morocho-Jácome, A.L.; Freire, T.B.; de Oliveira, A.C.; de Almeida, T.S.; Rosado, C.; Velasco, M.V.R.; Baby, A.R. In vivo SPF from multifunctional sunscreen systems developed with natural compounds—A review. J. Cosmet. Dermatol. 2021, 20, 729–737. [Google Scholar] [CrossRef]
  27. Katiyar, S.; Matsui, M.S.; Elmets, C.A.; Mukhtar, H. Polyphenolic antioxidant (-)-epigallocatechin-3-gallate from green tea reduces UVB-induced inflammatory responses and infiltration of leukocytes in human skin. Photochem. Photobiol. 1999, 69, 148–153. [Google Scholar] [CrossRef]
  28. Saija, A.; Tomaino, A.; Trombetta, D.; De Pasquale, A.; Uccella, N.; Barbuzzi, T.; Paolino, D.; Bonina, F. In vitro and in vivo evaluation of caffeic and ferulic acids as topical photoprotective agents. Int. J. Pharm. 2000, 199, 39–47. [Google Scholar] [CrossRef] [PubMed]
  29. Elmets, C.A.; Singh, D.; Tubesing, K.; Matsui, M.; Katiyar, S.; Mukhtar, H. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. J. Am. Acad. Dermatol. 2001, 44, 425–432. [Google Scholar] [CrossRef] [PubMed]
  30. Kim, J.; Hwang, J.S.; Cho, Y.K.; Han, Y.; Jeon, Y.J.; Yang, K.H. Protective effects of epigallocatechin-3-gallate on UVA and UVB-induced skin Damage. Ski. Pharmacol. Appl. Ski. Physiol. 2001, 14, 11–19. [Google Scholar] [CrossRef]
  31. Kitagawa, S.; Yoshii, K.; Morita, S.Y.; Teraoka, R. Efficient topical delivery of chlorogenic acid by an oil-in-water microemulsion to protect skin against UV-Induced damage. Chem. Pharm. Bull. 2011, 59, 793–796. [Google Scholar] [CrossRef]
  32. Choquenet, B.; Couteau, C.; Paparis, E.; Coiffard, L.J. Flavonoids and polyphenols, molecular families with sunscreen potential: Determining effectiveness with an in vitro method. Nat. Prod. Commun. 2009, 4, 227–230. [Google Scholar] [CrossRef]
  33. Stevanato, R.; Bertelle, M.; Fabris, S. Photoprotective characteristics of natural antioxidant polyphenols. Regul. Toxicol. Pharmacol. 2014, 69, 71–77. [Google Scholar] [CrossRef] [PubMed]
  34. Ácsová, A.; Hojerová, J.; Janotková, L.; Bendová, H.; Jedličková, L.; Hamranová, V.; Martiniaková, S. The real UVB photoprotective efficacy of vegetable oils: In vitro and in vivo studies. Photochem. Photobiol. Sci. 2021, 20, 139–151. [Google Scholar] [CrossRef]
  35. García-Forero, A.; Villamizar-Mantilla, D.A.; Núñez de Villavicencio-Martínez, L.A.; Ocazionez, R.E.; Stashenko, E.E.; Fuentes, J.L. Photoprotective and antigenotoxic effects of the flavonoids apigenin, naringenin and pinocembrin. Photochem. Photobiol. 2019, 95, 1010–1018. [Google Scholar] [CrossRef] [PubMed]
  36. Barrios Martínez, S.; Villamizar Mantilla, D.A.; Ocazionez, R.E.; Stashenko, E.E.; Vinardell, M.P.; Fuentes, J.L. Photoprotective and antigenotoxic effects of a mixture of Posoqueria latifolia flower extract and kaempferol against ultraviolet B radiation. Photochem. Photobiol. 2025, 101, 1454–1467. [Google Scholar] [CrossRef]
  37. Fuentes, J.L.; Pedraza-Barrera, C.A.; Flores-González, S.J.; Barrios-Martínez, S.X.; Sierra-Prada, L.J.; Ocazionez, R.E.; Stashenko, E.E. Flower extracts from ornamental plants as sources of sunscreen ingredients: Determination by in vitro methods of photoprotective efficacy, antigenotoxicity and safety. Molecules 2022, 27, 5525. [Google Scholar] [CrossRef]
  38. Park, E.S.; Na, J.I.; Kim, S.O.; Huh, C.H.; Youn, S.W.; Park, K.C. Application of a pigment measuring device–Mexameter–for the differential diagnosis of vitiligo and nevus depigmentosus. Ski. Res. Technol. 2006, 2, 298–302. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Different UVB-induced lesions in the skin of BALB/c mice.
Figure 1. Different UVB-induced lesions in the skin of BALB/c mice.
Life 16 00176 g001
Figure 2. Pooled dose–response curves to UVB radiation obtained from a total of 42 subjects (n = 21 female + 21 male).
Figure 2. Pooled dose–response curves to UVB radiation obtained from a total of 42 subjects (n = 21 female + 21 male).
Life 16 00176 g002
Table 1. Reflectance measurements before irradiation (t = 0 h) and after irradiation (t = 24 and 48 h) of different dorsal areas of female and male mouse skin. The EI values were calculated as follows: EI = reflectance in irradiated skin − reflectance in nonirradiated skin (in bold values). The average values and the corresponding standard errors, calculated from at least three animals (n = 3), are given.
Table 1. Reflectance measurements before irradiation (t = 0 h) and after irradiation (t = 24 and 48 h) of different dorsal areas of female and male mouse skin. The EI values were calculated as follows: EI = reflectance in irradiated skin − reflectance in nonirradiated skin (in bold values). The average values and the corresponding standard errors, calculated from at least three animals (n = 3), are given.
RadiationWeightReflectance and Erythema Measurements in Mouse Skin
Doses Upper Back Dorsal AreasMiddle Back Dorsal AreasLower Back Dorsal Areas
(mJ/cm2)(g)t (0 h)t (24 h)t (48 h)EI t (0 h)t (24 h)t (48 h)EI t (0 h)t (24 h)t (48 h)EI
Female
018.3 ± 1.2255 ± 0267 ± 2270 ± 015 ± 3178 ± 2180 ± 1185 ± 27 ± 1161 ± 2162 ± 2161 ± 20 ± 0
7018.1 ± 7.4260 ± 1283 ± 3349 ± 394 ± 3177 ± 1180 ± 3219 ± 441 ± 5 157 ± 1162 ± 2186 ± 125 ± 3
11218.2 ± 0.9268 ± 4296 ± 3418 ± 5163 ± 5176 ± 2204 ± 3235 ± 457 ± 4160 ± 2181 ± 3207 ± 346 ± 2
14019.0 ± 0.6272 ± 5326 ± 3485 ± 4230 ± 7188 ± 1210 ± 4268 ± 391 ± 3164 ± 2193 ± 3245 ± 384 ± 4
16818.2 ± 0.8275 ± 1335 ± 2512 ± 2257 ± 2184 ± 3224 ± 6275 ± 398 ± 3164 ± 5212 ± 3253 ± 792 ± 9
20017.2 ± 0.8263 ± 2306 ± 7501 ± 4246 ± 5186 ± 1217 ± 7309 ± 7131 ± 8159 ± 2207 ± 8271 ± 9110 ± 9
(R = 0.97 *) (R = 0.98 *) (R = 0.98 *)
Male
022.1 ± 0.5157 ± 3160 ± 3175 ± 418 ± 5103 ± 5109 ± 7115 ± 1112 ± 666 ± 372 ± 579 ± 513 ± 3
7022.9 ± 1.3140 ± 5176 ± 6178 ± 221 ± 480 ± 297 ± 4103 ± 40 ± 067 ± 788 ± 386 ± 220 ± 5
11224.3 ± 1.2160 ± 5171 ± 8182 ± 325 ± 283 ± 497 ± 4121 ± 418 ± 673 ± 789 ± 589 ± 423± 5
14023.1 ± 0.7163 ± 4187 ± 1202 ± 445 ± 395 ± 2105 ± 2126 ± 323 ± 580 ± 4102 ± 1112 ± 146 ± 2
16822.3 ± 1.3158 ± 2216 ± 3294 ± 4137 ± 5101 ± 5121 ± 5161 ± 358 ± 466 ± 378 ± 5154 ± 1088 ± 7
20021.0 ± 1.0166 ± 1294 ± 4326 ± 2169 ± 396 ± 4175 ± 3207 ± 2104 ± 786 ± 1114 ± 1175 ± 2109 ± 3
(R = 0.82 *) (R = 0.79 *) (R = 0.87 *)
, The EI values were calculated using reflectance measurements obtained 48 h post-irradiation [14]. *, Significant (p ˂ 0.05) correlation between radiation dose and erythema index (EI) values.
Table 2. Reflectance measurements pre-irradiation (t = 0 h) and post-irradiation (t = 24 and 48 h) of upper back dorsal skin area of female mice. The EI values were calculated as follows: EI = reflectance in irradiated skin (t = 48 h) − reflectance in nonirradiated skin (t = 0 h). The average values and the corresponding standard errors were calculated from at least three animals (n = 3). The EIP values (see Section 2) are also given.
Table 2. Reflectance measurements pre-irradiation (t = 0 h) and post-irradiation (t = 24 and 48 h) of upper back dorsal skin area of female mice. The EI values were calculated as follows: EI = reflectance in irradiated skin (t = 48 h) − reflectance in nonirradiated skin (t = 0 h). The average values and the corresponding standard errors were calculated from at least three animals (n = 3). The EIP values (see Section 2) are also given.
TreatmentsMice WeightReflectance and Erythema
Measurements of Mice Skin
EIP
(g)t (0 h)t (24 h)t (48 h)EI
Female mice
Untreated (negative control)18.3 ± 1.2255 ± 3267 ± 2270 ± 215 ± 3-
25% Glycerin (Gly)15.6 ± 0.3262 ± 2262 ± 2266 ± 213 ± 3-
UVB radiation (200 mJ/cm2)18.8 ± 1.2267 ± 2306 ± 7515 ± 3260 ± 3-
Gly + UVB radiation (200 mJ/cm2)17.6 ± 0.4252 ± 2301 ± 2489 ± 6234 ± 7-
Male mice
Untreated (negative control)22.9 ± 1.2140 ± 5160 ± 3175 ± 417 ± 5-
25% Glycerin (Gly)20.0 ± 1.4164 ± 2169 ± 2167 ± 21 ± 0-
UVB radiation (200 mJ/cm2)20.1 ± 2.4166 ± 1266 ± 5326 ± 4168 ± 4-
Gly + UVB radiation (200 mJ/cm2)24.5 ± 0.1171 ± 2274 ± 2337 ± 3166 ± 3-
Apigenin (evaluated in female mice)
Gly + apigenin (48.6 µg/cm2)19.7 ± 0.9264 ± 2265 ± 1266 ± 111 ± 495.3
Gly + apigenin + 200 mJ/cm217.6 ± 0.9265 ± 2302 ± 4318 ± 363 ± 4 *73.1
Gly + apigenin + 400 mJ/cm220.5 ± 0.4265 ± 2320 ± 2316 ± 261 ± 2 *73.9
Gly + apigenin + 600 mJ/cm218.2 ± 0.7263 ± 1414 ± 5510 ± 2234 ± 2 n.s.0.0
Caffeic acid (evaluated in male mice)
Gly + caffeic acid (80.7 μg/cm2)22.8 ± 1.4161 ± 1165 ± 1167 ± 21 ± 1 99.4
Gly + caffeic acid + 200 mJ/cm222.1 ± 0.4155 ± 1191 ± 3219 ± 347 ± 5 *71.7
Gly + caffeic acid + 600 mJ/cm223.8 ± 0.8161 ± 2209 ± 5220 ± 149 ± 2 *70.5
Gly + caffeic acid + 800 mJ/cm222.6 ± 0.6161 ± 2208 ± 1221 ± 250 ± 2 *69.9
Gly + caffeic acid + 1000 mJ/cm222.1 ± 1.0160 ± 2224 ± 2284 ± 2113 ± 1 n.s.0.0
EGCG (evaluated in male mice)
Gly + EGCG (198 µg/cm2)21.1 ± 0.5163 ± 1167 ± 2162 ± 31 ± 1 99.4
Gly + EGCG + 200 mJ/cm222.9 ± 0.6167 ± 2184 ± 2204 ± 232 ± 2 *63.8
Gly + EGCG + 400 mJ/cm222.8 ± 0.5158 ± 2219 ± 4268 ± 397 ± 5 *0.0
Gly + EGCG + 600 mJ/cm221.3 ± 0.3164 ± 2258 ± 4336 ± 3165 ± 5 n.s.0.0
Kaempferol (evaluated in female mice)
Gly + kaempferol (100 μg/cm2)19.2 ± 0.1264 ± 2268 ± 3290 ± 335 ± 3 85.0
Gly + kaempferol + 200 mJ/cm218.9 ± 0.1269 ± 1287 ± 4309 ± 154 ± 4 *76.9
Gly + kaempferol + 400 mJ/cm217.5 ± 0.2260 ± 2300 ± 3319 ± 364 ± 5 *72.6
Gly + kaempferol + 800 mJ/cm222.7 ± 2.8267 ± 2345 ± 7360 ± 4105 ± 5 *55.1
Gly + kaempferol + 1000 mJ/cm217.6 ± 0.4252 ± 2301 ± 2489 ± 6234 ± 7 n.s.0.0
Pinocembrin (evaluated in male mice)
Gly + pinocembrin (24.5 µg/cm2)18.6 ± 0.2168 ± 3163 ± 1165 ± 23 ± 1 98.2
Gly + pinocembrin + 200 mJ/cm223.8 ± 0.3165 ± 1183 ± 3185 ± 314 ± 4 *91.6
Gly + pinocembrin + 400 mJ/cm223.3 ± 0.9163 ± 2209 ± 6219 ± 447 ± 6 *66.4
Gly + pinocembrin + 800 mJ/cm220.8 ± 1.3161 ± 3271 ± 1302 ± 3140 ± 3 n.s.0.0
Titanium dioxide (evaluated in female mice)
Gly + titanium dioxide (500 µg/cm2)16.9 ± 1.0259 ± 1259 ± 1261 ± 27 ± 4-
Gly + titanium dioxide + 200 mJ/cm217.4 ± 0.4256 ± 1309 ± 3320 ± 265 ± 4 *72.2
Gly + titanium dioxide + 600 mJ/cm221.2 ± 3.2260 ± 2313 ± 3318 ± 263 ± 3 *73.1
Gly + titanium dioxide + 800 mJ/cm217.4 ± 3.6257 ± 2326 ± 4445 ± 2190 ± 4 *18.8
Gly + titanium dioxide + 1000 mJ/cm221.6 ± 1.7261 ± 2328 ± 3503 ± 3248 ± 6 n.s.0.0
Zinc oxide (evaluated in female mice)
Gly + zinc oxide (500 µg/cm2) 19.3 ± 0.1260 ± 2258 ± 1259 ± 26 ± 3 97.4
Gly + zinc oxide + 200 mJ/cm219.0 ± 0.3258 ± 2296 ± 2302 ± 247 ± 2 *79.9
Gly + zinc oxide + 600 mJ/cm218.8 ± 1.3258 ± 2300 ± 3315 ± 360 ± 5 *74.3
Gly + zinc oxide + 800 mJ/cm218.1 ± 0.5255 ± 1326 ± 4420 ± 4165 ± 3 *29.5
Gly + zinc oxide + 1000 mJ/cm217.8 ± 0.5256 ± 2336 ± 3469 ± 4260 ± 2 n.s.0.0
*, Significantly lower (p ˂ 0.05) EI values than in treatment with Gly + UVB radiation (200 mJ/cm2). n.s., non-significant inhibition.
Table 3. Minimal erythema doses of protected (MEDp) and unprotected (MEDu) mice. The erythema protective efficacy (EPE and EPEC) values for each treatment are also given. For each treatment, the expected SPF values (MEDp/human MEDu) for each human phototype (I–IV) are also shown.
Table 3. Minimal erythema doses of protected (MEDp) and unprotected (MEDu) mice. The erythema protective efficacy (EPE and EPEC) values for each treatment are also given. For each treatment, the expected SPF values (MEDp/human MEDu) for each human phototype (I–IV) are also shown.
Tested Samples (Mass) SPFin vitro *MEDuMEDpEPEEPECExpected SPF Values for Human Phototypes
(mJ/cm2)(mJ/cm2) Type IType IIType IIIType IV
Glycerin 25% (solvent) 39–8039–801.0 ± 0.01.0 ± 0.0----
Apigenin (48.6 µg)11 ± 039 40015.4 ± 0.019.9 ± 0.011.4 ± 0.07.1 ± 0.05.7 ± 0.04.8 ± 0.0
Caffeic acid (80.7 µg)36 ± 18080010.0 ± 0.013.4 ± 0.022.8 ± 0.014.3 ± 0.05.7 ± 0.04.8 ± 0.0
EGCG (198 µg) 19 ± 0802002.5 ± 0.03.4 ± 0.05.7 ± 0.03.6 ± 0.02.8 ± 0.02.4 ± 0.0
Kaempferol (100 µg)13 ± 039 80020.5 ± 0.023.4 ± 0.011.4 ± 0.07.1 ± 0.05.7 ± 0.04.8 ± 0.0
Pinocembrin (24.5 µg) 9 ± 0804005.0 ± 0.07.6 ± 0.011.4 ± 0.07.1 ± 0.05.7 ± 0.04.8 ± 0.0
Titanium dioxide (500 µg) 40 ± 039 60015.4 ± 0.020.1 ± 0.017.1 ± 0.010.7 ± 0.08.6 ± 0.07.1 ± 0.0
Zinc oxide (500 µg) 40 ± 039 60015.4 ± 0.020.1 ± 0.017.1 ± 0.010.7 ± 0.08.6 ± 0.07.1 ± 0.0
R1 = 0.56 (p ˂ 0.14)R1 = 0.55 (p ˂ 0.15)R1 = 0.75 (p ˂ 0.03)R1 = 0.75 (p ˂ 0.03)
R2 = 0.63 (p ˂ 0.09)R2 = 0.62 (p ˂ 0.10)R2 = 0.81 (p ˂ 0.01)R2 = 0.81 (p ˂ 0.01)
, Mass of compounds that were not cytotoxic to human fibroblast cells [17]. , Mass of standard UV filter used for sunscreen preparation based on FDA guidelines [18]. *, SPFin vitro values were previously reported for each compound [17]. The MDE values for each human skin phototype were as follows: type I (35 mJ/cm2), type II (56 mJ/cm2), type III (70 mJ/cm2), and type IV (84 mJ/cm2) [19]. R1, Pearson’s product–moment correlation coefficient between EPE and SPF estimates calculated using R platform [15]. R2, Pearson’s product-moment correlation coefficient between EPEC and SPF estimates using R platform [15].
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Villamizar Mantilla, D.A.; Nuñez, L.A.; Stashenko, E.E.; Vinardell, M.P.; Fuentes, J.L. Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data. Life 2026, 16, 176. https://doi.org/10.3390/life16010176

AMA Style

Villamizar Mantilla DA, Nuñez LA, Stashenko EE, Vinardell MP, Fuentes JL. Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data. Life. 2026; 16(1):176. https://doi.org/10.3390/life16010176

Chicago/Turabian Style

Villamizar Mantilla, Diego Armando, Luis Alberto Nuñez, Elena E. Stashenko, María Pilar Vinardell, and Jorge Luis Fuentes. 2026. "Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data" Life 16, no. 1: 176. https://doi.org/10.3390/life16010176

APA Style

Villamizar Mantilla, D. A., Nuñez, L. A., Stashenko, E. E., Vinardell, M. P., & Fuentes, J. L. (2026). Erythema Protection Efficacy of Plant-Derivative Compounds in Mice Based on Narrow-Band Reflectance Spectroscopy Data. Life, 16(1), 176. https://doi.org/10.3390/life16010176

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop